Skip to content

Clinical trials

Phase 2 Major Depressive Disorder trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Major Depressive Disorder Phase: Phase 2 Clear all

398 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20014
20024
20039
200410
200510
200610
200718
200824
200916
201015
201115
201214
201313
201415
201512
201613
201712
201814
201913
202015
202123
202215
202320
202431
202524
202623

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed259
Recruiting46
Terminated38
Unknown status21
Withdrawn13
Active, not recruiting10
Not yet recruiting8
Suspended2
Enrolling by invitation1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
National Institute of Mental Health (NIMH)15
GlaxoSmithKline14
Janssen Research & Development, LLC14
Massachusetts General Hospital14
Alto Neuroscience7
H. Lundbeck A/S7
Icahn School of Medicine at Mount Sinai7
AstraZeneca6
Otsuka Pharmaceutical Development & Commercialization, Inc.6
Shanghai Mental Health Center6

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Major Depressive Disorder398
Depressive Disorder40
Depressive Disorder, Treatment-Resistant40
Mood Disorders30
Anxiety Disorders16
Mental Disorders15
Bipolar Disorder13
Inflammation10
Alcoholism9
Anhedonia7

Trials

Showing 26 to 50 of 398. Each trial links to its page on Pharma Observatory.

298 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.